Just out: An interview with Jacob van Naarden on his (and Lilly’s) views of radiotheranostics. @hadaschik.bsky.social @snm-mi.bsky.social @drmhofman.bsky.social

Fractionated radiopharmaceutical therapy with ²¹³Bi-FAPI-46 can be considered a personalized therapeutic approach for end-stage cancer patients. ow.ly/fFCJ50U4BZQ

#RPTherapy #NuclearMedicine #Cancer